Clinical efficacy of moxifloxacin in the treatment of Mycoplasma pneumonia

Chinese Journal of Infection and Chemotherapy

Volumn 10, Issue 5, 2010, Pages 349-353

  Liu, Yi ^a   Li, Jian ^a   Liu, Ying ^a   Liao, Liju ^a   Yu, Hong ^a   Zhang, Bo ^a  

^a AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Azithromycin; Moxifloxacin; Mycoplasma pneumonia

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; MOXIFLOXACIN;

ADULT; ARTICLE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MONOTHERAPY; MYCOPLASMA PNEUMONIA; RANDOMIZED CONTROLLED TRIAL;

EID: 77958006063     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Beovió B, Bonaó B, Keó D, et al . Aetiology and clinical presentation of mild community-acquired bacterial pneumonia [J]. Eur J Clin Microbiol fnfect Dis, 2003, 22(10): 584-591.
2. Talkington DF, Thacker WL, Keller DW, et al. Diagnosis of Mycoplasma pneumoniae infection in autopsy and open-lung biopsy tissues by nested PCR[J]. J Clin Microbiol, 1998, 36 (4).1151-1153.
3. Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia[J]. Antimicrob Agents Chemother, 2008,52(1) :348-350.
4. Isozumi R, Yoshimine H, Morozumi M, et al. Adult communityacquired pneumonia caused by macrolide resistant Mycoplasma pneumoniaf [J]. Respirology, 2009,14(8) :1206-1208.
5. Dumke R, von Baum H, Luck PC, et al. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany [J]. Clin Microbiol fnfect,2010,16(6) :613-616.
6. Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China[J]. Antimicrob Agents Chemother, 2009, 53 (2),2158-2159.
7. Ramirez JA, Srinath L, Amkee S, et al. Early switch from intravenous to oral cephalosporin in the treatment of hospitalized patients with community-acquired pneumonia [J]. Arch Intern Med, 1995,155(12) :1273-1276.
8. Siegel RE, Halpern NA, Almenoff PL, et al. 1996. A prospective randomized study of inpatient IV antibiotics for community acquired pneumonia. The optimum duration of therapy[J]. Chest,1996, 110(4), 965-971.
9. Fine MJ, Pratt HM, Obrosky DS, et al. Relation between length of hospital stay and cost of care for patients with community-acquired pneumonia [J]. Am J Med, 2000,109(5), 378-385.